173 related articles for article (PubMed ID: 26011146)
1. Inhibition of 11β-Hydroxysteroid Dehydrogenase Type II Suppresses Lung Carcinogenesis by Blocking Tumor COX-2 Expression as Well as the ERK and mTOR Signaling Pathways.
Chang J; Xue M; Yang S; Yao B; Zhang B; Chen X; Pozzi A; Zhang MZ
PLoS One; 2015; 10(5):e0127030. PubMed ID: 26011146
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of 11beta-hydroxysteroid dehydrogenase type II selectively blocks the tumor COX-2 pathway and suppresses colon carcinogenesis in mice and humans.
Zhang MZ; Xu J; Yao B; Yin H; Cai Q; Shrubsole MJ; Chen X; Kon V; Zheng W; Pozzi A; Harris RC
J Clin Invest; 2009 Apr; 119(4):876-85. PubMed ID: 19307727
[TBL] [Abstract][Full Text] [Related]
3. Epithelial-specific deletion of 11β-HSD2 hinders Apcmin/+ mouse tumorigenesis.
Jiang L; Yang S; Yin H; Fan X; Wang S; Yao B; Pozzi A; Chen X; Harris RC; Zhang MZ
Mol Cancer Res; 2013 Sep; 11(9):1040-50. PubMed ID: 23741059
[TBL] [Abstract][Full Text] [Related]
4. 11β-Hydroxysteroid Dehydrogenase Type II is a Potential Target for Prevention of Colorectal Tumorigenesis.
Yang S; Jiang L; Zhang MZ
J Oncobiomarkers; 2013; 1(1):. PubMed ID: 23936870
[TBL] [Abstract][Full Text] [Related]
5. Melatonin inhibits AP-2β/hTERT, NF-κB/COX-2 and Akt/ERK and activates caspase/Cyto C signaling to enhance the antitumor activity of berberine in lung cancer cells.
Lu JJ; Fu L; Tang Z; Zhang C; Qin L; Wang J; Yu Z; Shi D; Xiao X; Xie F; Huang W; Deng W
Oncotarget; 2016 Jan; 7(3):2985-3001. PubMed ID: 26672764
[TBL] [Abstract][Full Text] [Related]
6. Deletion of cyclooxygenase-2 inhibits K-ras-induced lung carcinogenesis.
Pan Y; Jiang Y; Tan L; Ravoori MK; Gagea M; Kundra V; Fischer SM; Yang P
Oncotarget; 2015 Nov; 6(36):38816-26. PubMed ID: 26452035
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2 up-regulates ataxia telangiectasia and Rad3 related through extracellular signal-regulated kinase activation.
Kim YM; Lee EJ; Park SY; Cho KH; Kim JY; Pyo H
Mol Cancer Res; 2009 Jul; 7(7):1158-68. PubMed ID: 19584262
[TBL] [Abstract][Full Text] [Related]
8. Selenium regulates cyclooxygenase-2 and extracellular signal-regulated kinase signaling pathways by activating AMP-activated protein kinase in colon cancer cells.
Hwang JT; Kim YM; Surh YJ; Baik HW; Lee SK; Ha J; Park OJ
Cancer Res; 2006 Oct; 66(20):10057-63. PubMed ID: 17047069
[TBL] [Abstract][Full Text] [Related]
9. Epimagnolin targeting on an active pocket of mammalian target of rapamycin suppressed cell transformation and colony growth of lung cancer cells.
Yoo SM; Lee CJ; Kang HC; Lee HS; Lee JY; Kim KD; Kim DJ; An HJ; Cho YY
Mol Carcinog; 2019 Jul; 58(7):1221-1233. PubMed ID: 30887599
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner.
Krysan K; Reckamp KL; Dalwadi H; Sharma S; Rozengurt E; Dohadwala M; Dubinett SM
Cancer Res; 2005 Jul; 65(14):6275-81. PubMed ID: 16024629
[TBL] [Abstract][Full Text] [Related]
11. Hydroxysafflor yellow A inhibited lipopolysaccharide-induced non-small cell lung cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT/mTOR and ERK/MAPK signaling pathways.
Jiang M; Zhou LY; Xu N; An Q
Thorac Cancer; 2019 Jun; 10(6):1319-1333. PubMed ID: 31055884
[TBL] [Abstract][Full Text] [Related]
12. A Ferulic Acid Derivative FXS-3 Inhibits Proliferation and Metastasis of Human Lung Cancer A549 Cells via Positive JNK Signaling Pathway and Negative ERK/p38, AKT/mTOR and MEK/ERK Signaling Pathways.
Yue SJ; Zhang PX; Zhu Y; Li NG; Chen YY; Li JJ; Zhang S; Jin RY; Yan H; Shi XQ; Tang YP; Duan JA
Molecules; 2019 Jun; 24(11):. PubMed ID: 31181779
[TBL] [Abstract][Full Text] [Related]
13. Dual inhibition of the PI3K/AKT/mTOR pathway suppresses the growth of leiomyosarcomas but leads to ERK activation through mTORC2: biological and clinical implications.
Fourneaux B; Chaire V; Lucchesi C; Karanian M; Pineau R; Laroche-Clary A; Italiano A
Oncotarget; 2017 Jan; 8(5):7878-7890. PubMed ID: 28002802
[TBL] [Abstract][Full Text] [Related]
14. Induction of COX-2 protein expression by vanadate in A549 human lung carcinoma cell line through EGF receptor and p38 MAPK-mediated pathway.
Chien PS; Mak OT; Huang HJ
Biochem Biophys Res Commun; 2006 Jan; 339(2):562-8. PubMed ID: 16300728
[TBL] [Abstract][Full Text] [Related]
15. Harnessing the gatekeepers of glucocorticoids for chemoprevention of non-melanoma skin cancer.
Mancha-Ramirez AM; Yang X; Liang H; Junco J; Lee KP; Bovio SF; Espinoza M; Wool J; Slaga A; Glade DC; Hanes M; Malik G; Kim DJ; DiGiovanni J; Slaga TJ
Mol Carcinog; 2019 Jan; 58(1):102-112. PubMed ID: 30302860
[TBL] [Abstract][Full Text] [Related]
16. Interactions between 11beta-hydroxysteroid dehydrogenase and COX-2 in kidney.
Yao B; Harris RC; Zhang MZ
Am J Physiol Regul Integr Comp Physiol; 2005 Jun; 288(6):R1767-73. PubMed ID: 15718388
[TBL] [Abstract][Full Text] [Related]
17. Activation of endoplasmic reticulum stress promotes autophagy and apoptosis and reverses chemoresistance of human small cell lung cancer cells by inhibiting the PI3K/AKT/mTOR signaling pathway.
Yu XS; Du J; Fan YJ; Liu FJ; Cao LL; Liang N; Xu DG; Zhang JD
Oncotarget; 2016 Nov; 7(47):76827-76839. PubMed ID: 27765907
[TBL] [Abstract][Full Text] [Related]
18. Mitogenic signal transduction caused by monomethylarsonous acid in human bladder cells: role in arsenic-induced carcinogenesis.
Eblin KE; Bredfeldt TG; Buffington S; Gandolfi AJ
Toxicol Sci; 2007 Feb; 95(2):321-30. PubMed ID: 17093206
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor-induced cyclooxygenase-2 expression is mediated through phosphatidylinositol-3 kinase, not mitogen-activated protein/extracellular signal-regulated kinase kinase, in recurrent respiratory papillomas.
Wu R; Abramson AL; Shikowitz MJ; Dannenberg AJ; Steinberg BM
Clin Cancer Res; 2005 Sep; 11(17):6155-61. PubMed ID: 16144915
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 expression is abundant in alveolar type II cells in lung cancer-sensitive mouse strains and in premalignant lesions.
Wardlaw SA; March TH; Belinsky SA
Carcinogenesis; 2000 Jul; 21(7):1371-7. PubMed ID: 10874016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
